Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.

The fibrinolytic factor tPA drives LRP1-mediated melanoma growth and metastasis.

Salama Y, Lin SY, Dhahri D, Hattori K, Heissig B.

FASEB J. 2019 Mar;33(3):3465-3480. doi: 10.1096/fj.201801339RRR. Epub 2018 Nov 20.

PMID:
30458112
2.

The angiogenic factor Egfl7 alters thymogenesis by activating Flt3 signaling.

Salama Y, Hattori K, Heissig B.

Biochem Biophys Res Commun. 2017 Aug 19;490(2):209-216. doi: 10.1016/j.bbrc.2017.06.023. Epub 2017 Jun 8.

PMID:
28601636
3.

The role of plasmin in the pathogenesis of murine multiple myeloma.

Eiamboonsert S, Salama Y, Watarai H, Dhahri D, Tsuda Y, Okada Y, Hattori K, Heissig B.

Biochem Biophys Res Commun. 2017 Jun 24;488(2):387-392. doi: 10.1016/j.bbrc.2017.05.062. Epub 2017 May 10.

PMID:
28501622
4.

Pharmacological targeting of plasmin prevents lethality in a murine model of macrophage activation syndrome.

Shimazu H, Munakata S, Tashiro Y, Salama Y, Dhahri D, Eiamboonsert S, Ota Y, Onoda H, Tsuda Y, Okada Y, Nakauchi H, Heissig B, Hattori K.

Blood. 2017 Jul 6;130(1):59-72. doi: 10.1182/blood-2016-09-738096. Epub 2017 Mar 21.

5.

Plasminogen activator inhibitor-1 regulates macrophage-dependent postoperative adhesion by enhancing EGF-HER1 signaling in mice.

Honjo K, Munakata S, Tashiro Y, Salama Y, Shimazu H, Eiamboonsert S, Dhahri D, Ichimura A, Dan T, Miyata T, Takeda K, Sakamoto K, Hattori K, Heissig B.

FASEB J. 2017 Jun;31(6):2625-2637. doi: 10.1096/fj.201600871RR. Epub 2017 Mar 7.

PMID:
28270519
6.

Fibrinolytic crosstalk with endothelial cells expands murine mesenchymal stromal cells.

Dhahri D, Sato-Kusubata K, Ohki-Koizumi M, Nishida C, Tashiro Y, Munakata S, Shimazu H, Salama Y, Eiamboonsert S, Nakauchi H, Hattori K, Heissig B.

Blood. 2016 Aug 25;128(8):1063-75. doi: 10.1182/blood-2015-10-673103. Epub 2016 Jun 9.

7.

Cancer therapy targeting the fibrinolytic system.

Heissig B, Eiamboonsert S, Salama Y, Shimazu H, Dhahri D, Munakata S, Tashiro Y, Hattori K.

Adv Drug Deliv Rev. 2016 Apr 1;99(Pt B):172-179. doi: 10.1016/j.addr.2015.11.010. Epub 2015 Nov 14. Review.

PMID:
26588878
8.

Role of mesenchymal stem cell-derived fibrinolytic factor in tissue regeneration and cancer progression.

Heissig B, Dhahri D, Eiamboonsert S, Salama Y, Shimazu H, Munakata S, Hattori K.

Cell Mol Life Sci. 2015 Dec;72(24):4759-70. doi: 10.1007/s00018-015-2035-7. Epub 2015 Sep 9. Review.

PMID:
26350342
9.

Inhibition of plasmin protects against colitis in mice by suppressing matrix metalloproteinase 9-mediated cytokine release from myeloid cells.

Munakata S, Tashiro Y, Nishida C, Sato A, Komiyama H, Shimazu H, Dhahri D, Salama Y, Eiamboonsert S, Takeda K, Yagita H, Tsuda Y, Okada Y, Nakauchi H, Sakamoto K, Heissig B, Hattori K.

Gastroenterology. 2015 Mar;148(3):565-578.e4. doi: 10.1053/j.gastro.2014.12.001. Epub 2014 Dec 6.

PMID:
25490065
10.

Hes1 promotes blast crisis in chronic myelogenous leukemia through MMP-9 upregulation in leukemic cells.

Nakahara F, Kitaura J, Uchida T, Nishida C, Togami K, Inoue D, Matsukawa T, Kagiyama Y, Enomoto Y, Kawabata KC, Chen-Yi L, Komeno Y, Izawa K, Oki T, Nagae G, Harada Y, Harada H, Otsu M, Aburatani H, Heissig B, Hattori K, Kitamura T.

Blood. 2014 Jun 19;123(25):3932-42. doi: 10.1182/blood-2013-01-476747. Epub 2014 May 13.

11.

Inhibition of plasmin attenuates murine acute graft-versus-host disease mortality by suppressing the matrix metalloproteinase-9-dependent inflammatory cytokine storm and effector cell trafficking.

Sato A, Nishida C, Sato-Kusubata K, Ishihara M, Tashiro Y, Gritli I, Shimazu H, Munakata S, Yagita H, Okumura K, Tsuda Y, Okada Y, Tojo A, Nakauchi H, Takahashi S, Heissig B, Hattori K.

Leukemia. 2015 Jan;29(1):145-56. doi: 10.1038/leu.2014.151. Epub 2014 May 5.

PMID:
24791857
12.

Bone marrow-derived CD11b+Jagged2+ cells promote epithelial-to-mesenchymal transition and metastasization in colorectal cancer.

Caiado F, Carvalho T, Rosa I, Remédio L, Costa A, Matos J, Heissig B, Yagita H, Hattori K, da Silva JP, Fidalgo P, Pereira AD, Dias S.

Cancer Res. 2013 Jul 15;73(14):4233-46. doi: 10.1158/0008-5472.CAN-13-0085. Epub 2013 May 30.

13.

Inhibition of PAI-1 induces neutrophil-driven neoangiogenesis and promotes tissue regeneration via production of angiocrine factors in mice.

Tashiro Y, Nishida C, Sato-Kusubata K, Ohki-Koizumi M, Ishihara M, Sato A, Gritli I, Komiyama H, Sato Y, Dan T, Miyata T, Okumura K, Tomiki Y, Sakamoto K, Nakauchi H, Heissig B, Hattori K.

Blood. 2012 Jun 28;119(26):6382-93. doi: 10.1182/blood-2011-12-399659. Epub 2012 May 9.

14.

MT1-MMP plays a critical role in hematopoiesis by regulating HIF-mediated chemokine/cytokine gene transcription within niche cells.

Nishida C, Kusubata K, Tashiro Y, Gritli I, Sato A, Ohki-Koizumi M, Morita Y, Nagano M, Sakamoto T, Koshikawa N, Kuchimaru T, Kizaka-Kondoh S, Seiki M, Nakauchi H, Heissig B, Hattori K.

Blood. 2012 Jun 7;119(23):5405-16. doi: 10.1182/blood-2011-11-390849. Epub 2012 Apr 27.

15.

New functions of the fibrinolytic system in bone marrow cell-derived angiogenesis.

Heissig B, Ohki-Koizumi M, Tashiro Y, Gritli I, Sato-Kusubata K, Hattori K.

Int J Hematol. 2012 Feb;95(2):131-7. doi: 10.1007/s12185-012-1016-y. Epub 2012 Feb 7. Review.

PMID:
22311463
16.

Plasminogen deficiency attenuates postnatal erythropoiesis in male C57BL/6 mice through decreased activity of the LH-testosterone axis.

Okaji Y, Tashiro Y, Gritli I, Nishida C, Sato A, Ueno Y, Del Canto Gonzalez S, Ohki-Koizumi M, Akiyama H, Nakauchi H, Hattori K, Heissig B.

Exp Hematol. 2012 Feb;40(2):143-54. doi: 10.1016/j.exphem.2011.10.008. Epub 2011 Nov 3.

PMID:
22056679
17.

Plasmin inhibitor reduces T-cell lymphoid tumor growth by suppressing matrix metalloproteinase-9-dependent CD11b(+)/F4/80(+) myeloid cell recruitment.

Ishihara M, Nishida C, Tashiro Y, Gritli I, Rosenkvist J, Koizumi M, Okaji Y, Yamamoto R, Yagita H, Okumura K, Nishikori M, Wanaka K, Tsuda Y, Okada Y, Nakauchi H, Heissig B, Hattori K.

Leukemia. 2012 Feb;26(2):332-9. doi: 10.1038/leu.2011.203. Epub 2011 Sep 20.

PMID:
21931322
18.

Tumor necrosis factor receptor-associated factor (TRAF) 2 controls homeostasis of the colon to prevent spontaneous development of murine inflammatory bowel disease.

Piao JH, Hasegawa M, Heissig B, Hattori K, Takeda K, Iwakura Y, Okumura K, Inohara N, Nakano H.

J Biol Chem. 2011 May 20;286(20):17879-88. doi: 10.1074/jbc.M111.221853. Epub 2011 Mar 10.

19.

Adipocyte-derived microvesicles are associated with multiple angiogenic factors and induce angiogenesis in vivo and in vitro.

Aoki N, Yokoyama R, Asai N, Ohki M, Ohki Y, Kusubata K, Heissig B, Hattori K, Nakagawa Y, Matsuda T.

Endocrinology. 2010 Jun;151(6):2567-76. doi: 10.1210/en.2009-1023. Epub 2010 Apr 9. Retraction in: Endocrinology. 2013 Nov;154(11):4437.

PMID:
20382694
20.

Role of neutrophil-derived matrix metalloproteinase-9 in tissue regeneration.

Heissig B, Nishida C, Tashiro Y, Sato Y, Ishihara M, Ohki M, Gritli I, Rosenkvist J, Hattori K.

Histol Histopathol. 2010 Jun;25(6):765-70. doi: 10.14670/HH-25.765. Review.

PMID:
20376783
21.

Tissue type plasminogen activator regulates myeloid-cell dependent neoangiogenesis during tissue regeneration.

Ohki M, Ohki Y, Ishihara M, Nishida C, Tashiro Y, Akiyama H, Komiyama H, Lund LR, Nitta A, Yamada K, Zhu Z, Ogawa H, Yagita H, Okumura K, Nakauchi H, Werb Z, Heissig B, Hattori K.

Blood. 2010 May 27;115(21):4302-12. doi: 10.1182/blood-2009-08-236851. Epub 2010 Jan 28.

22.

Contribution of the fibrinolytic pathway to hematopoietic regeneration.

Heissig B, Ohki M, Ishihara M, Tashiro Y, Nishida C, Gritli I, Rosenkvist J, Hattori K.

J Cell Physiol. 2009 Dec;221(3):521-5. doi: 10.1002/jcp.21897. Review.

PMID:
19681053
23.

Endothelial progenitor cells are cellular hubs essential for neoangiogenesis of certain aggressive adenocarcinomas and metastatic transition but not adenomas.

Kerbel RS, Benezra R, Lyden DC, Hattori K, Heissig B, Nolan DJ, Mittal V, Shaked Y, Dias S, Bertolini F, Rafii S.

Proc Natl Acad Sci U S A. 2008 Aug 26;105(34):E54; author reply E55. doi: 10.1073/pnas.0804876105. Epub 2008 Aug 20. No abstract available.

24.

Metalloproteinase regulation improves in vitro generation of efficacious platelets from mouse embryonic stem cells.

Nishikii H, Eto K, Tamura N, Hattori K, Heissig B, Kanaji T, Sawaguchi A, Goto S, Ware J, Nakauchi H.

J Exp Med. 2008 Aug 4;205(8):1917-27. doi: 10.1084/jem.20071482. Epub 2008 Jul 28.

25.

[Bone marrow-derived cells contribute to niche formation in cancer progression].

Hattori K, Ishihara M, Heissig B.

Clin Calcium. 2008 Apr;18(4):480-7. doi: CliCa0804480487. Review. Japanese.

PMID:
18379030
26.

The plasminogen fibrinolytic pathway is required for hematopoietic regeneration.

Heissig B, Lund LR, Akiyama H, Ohki M, Morita Y, Rømer J, Nakauchi H, Okumura K, Ogawa H, Werb Z, Danø K, Hattori K.

Cell Stem Cell. 2007 Dec 13;1(6):658-70. doi: 10.1016/j.stem.2007.10.012. Erratum in: Cell Stem Cell. 2008 Jul 3;3(1):120.

27.

Matrix metalloproteinase-9 regulates TNF-alpha and FasL expression in neuronal, glial cells and its absence extends life in a transgenic mouse model of amyotrophic lateral sclerosis.

Kiaei M, Kipiani K, Calingasan NY, Wille E, Chen J, Heissig B, Rafii S, Lorenzl S, Beal MF.

Exp Neurol. 2007 May;205(1):74-81. Epub 2007 Feb 12.

PMID:
17362932
28.

Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytes.

Jin DK, Shido K, Kopp HG, Petit I, Shmelkov SV, Young LM, Hooper AT, Amano H, Avecilla ST, Heissig B, Hattori K, Zhang F, Hicklin DJ, Wu Y, Zhu Z, Dunn A, Salari H, Werb Z, Hackett NR, Crystal RG, Lyden D, Rafii S.

Nat Med. 2006 May;12(5):557-67. Epub 2006 Apr 30. Erratum in: Nat Med. 2006 Aug;12(8):978.

30.

Granulocyte colony-stimulating factor promotes neovascularization by releasing vascular endothelial growth factor from neutrophils.

Ohki Y, Heissig B, Sato Y, Akiyama H, Zhu Z, Hicklin DJ, Shimada K, Ogawa H, Daida H, Hattori K, Ohsaka A.

FASEB J. 2005 Dec;19(14):2005-7. Epub 2005 Oct 13.

PMID:
16223785
31.

Low-dose irradiation promotes tissue revascularization through VEGF release from mast cells and MMP-9-mediated progenitor cell mobilization.

Heissig B, Rafii S, Akiyama H, Ohki Y, Sato Y, Rafael T, Zhu Z, Hicklin DJ, Okumura K, Ogawa H, Werb Z, Hattori K.

J Exp Med. 2005 Sep 19;202(6):739-50. Epub 2005 Sep 12.

32.

A role for niches in hematopoietic cell development.

Heissig B, Ohki Y, Sato Y, Rafii S, Werb Z, Hattori K.

Hematology. 2005 Jun;10(3):247-53.

PMID:
16019473
33.

Chemokine-mediated interaction of hematopoietic progenitors with the bone marrow vascular niche is required for thrombopoiesis.

Avecilla ST, Hattori K, Heissig B, Tejada R, Liao F, Shido K, Jin DK, Dias S, Zhang F, Hartman TE, Hackett NR, Crystal RG, Witte L, Hicklin DJ, Bohlen P, Eaton D, Lyden D, de Sauvage F, Rafii S.

Nat Med. 2004 Jan;10(1):64-71. Epub 2003 Dec 21.

PMID:
14702636
34.

Role of c-kit/Kit ligand signaling in regulating vasculogenesis.

Heissig B, Werb Z, Rafii S, Hattori K.

Thromb Haemost. 2003 Oct;90(4):570-6. Review.

PMID:
14515175
35.

Angiogenic factors reconstitute hematopoiesis by recruiting stem cells from bone marrow microenvironment.

Rafii S, Avecilla S, Shmelkov S, Shido K, Tejada R, Moore MA, Heissig B, Hattori K.

Ann N Y Acad Sci. 2003 May;996:49-60.

PMID:
12799282
36.

The regulation of hematopoietic stem cell and progenitor mobilization by chemokine SDF-1.

Hattori K, Heissig B, Rafii S.

Leuk Lymphoma. 2003 Apr;44(4):575-82.

PMID:
12769333
37.

Molecular pathways regulating mobilization of marrow-derived stem cells for tissue revascularization.

Rabbany SY, Heissig B, Hattori K, Rafii S.

Trends Mol Med. 2003 Mar;9(3):109-17. Review.

PMID:
12657432
38.

Angiogenesis: vascular remodeling of the extracellular matrix involves metalloproteinases.

Heissig B, Hattori K, Friedrich M, Rafii S, Werb Z.

Curr Opin Hematol. 2003 Mar;10(2):136-41. Review.

PMID:
12579040
39.

Vascular and haematopoietic stem cells: novel targets for anti-angiogenesis therapy?

Rafii S, Lyden D, Benezra R, Hattori K, Heissig B.

Nat Rev Cancer. 2002 Nov;2(11):826-35. Review. No abstract available.

PMID:
12415253
40.

Interleukin-1alpha promotes angiogenesis in vivo via VEGFR-2 pathway by inducing inflammatory cell VEGF synthesis and secretion.

Salven P, Hattori K, Heissig B, Rafii S.

FASEB J. 2002 Sep;16(11):1471-3. Epub 2002 Jul 18.

PMID:
12205052
41.

Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1(+) stem cells from bone-marrow microenvironment.

Hattori K, Heissig B, Wu Y, Dias S, Tejada R, Ferris B, Hicklin DJ, Zhu Z, Bohlen P, Witte L, Hendrikx J, Hackett NR, Crystal RG, Moore MA, Werb Z, Lyden D, Rafii S.

Nat Med. 2002 Aug;8(8):841-9. Epub 2002 Jul 1.

42.

Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand.

Heissig B, Hattori K, Dias S, Friedrich M, Ferris B, Hackett NR, Crystal RG, Besmer P, Lyden D, Moore MA, Werb Z, Rafii S.

Cell. 2002 May 31;109(5):625-37.

44.

Contribution of marrow-derived progenitors to vascular and cardiac regeneration.

Rafii S, Meeus S, Dias S, Hattori K, Heissig B, Shmelkov S, Rafii D, Lyden D.

Semin Cell Dev Biol. 2002 Feb;13(1):61-7. Review.

PMID:
11969372
45.

Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth.

Lyden D, Hattori K, Dias S, Costa C, Blaikie P, Butros L, Chadburn A, Heissig B, Marks W, Witte L, Wu Y, Hicklin D, Zhu Z, Hackett NR, Crystal RG, Moore MA, Hajjar KA, Manova K, Benezra R, Rafii S.

Nat Med. 2001 Nov;7(11):1194-201.

PMID:
11689883
46.

Inhibition of both paracrine and autocrine VEGF/ VEGFR-2 signaling pathways is essential to induce long-term remission of xenotransplanted human leukemias.

Dias S, Hattori K, Heissig B, Zhu Z, Wu Y, Witte L, Hicklin DJ, Tateno M, Bohlen P, Moore MA, Rafii S.

Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10857-62.

47.

Mobilization of endothelial and hematopoietic stem and progenitor cells by adenovector-mediated elevation of serum levels of SDF-1, VEGF, and angiopoietin-1.

Moore MA, Hattori K, Heissig B, Shieh JH, Dias S, Crystal RG, Rafii S.

Ann N Y Acad Sci. 2001 Jun;938:36-45; discussion 45-7.

PMID:
11458524
48.

Plasma elevation of stromal cell-derived factor-1 induces mobilization of mature and immature hematopoietic progenitor and stem cells.

Hattori K, Heissig B, Tashiro K, Honjo T, Tateno M, Shieh JH, Hackett NR, Quitoriano MS, Crystal RG, Rafii S, Moore MA.

Blood. 2001 Jun 1;97(11):3354-60.

49.

Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells.

Hattori K, Dias S, Heissig B, Hackett NR, Lyden D, Tateno M, Hicklin DJ, Zhu Z, Witte L, Crystal RG, Moore MA, Rafii S.

J Exp Med. 2001 May 7;193(9):1005-14.

50.

Supplemental Content

Loading ...
Support Center